AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer’s disease
Pharmaceutical Investing Denali Therapeutics Announces Reports Full Year 2017 Financial Results And Business Highlights
Pharmaceutical Investing Novartis and Pear Therapeutics to develop digital therapeutics for patients with schizophrenia and multiple sclerosis
ProMIS Neurosciences Lead Product Candidate for Alzheimer’s Disease Shows Potential for Improved Therapeutic Potency
Blue Lagoon Resources to Showcase Dome Mountain Gold Project at 121 Mining Investment Conference in London
American Salars Starts Sampling at 100% Owned Brazilian LCT Pegmatite Project, with Past Samples Hitting 3.72% Li2o and Significant Ree Values
Heritage Mining Announces Encouraging Gold Results from New Millennium Drill Program and provides Exploration Update and Strategic Investment
